Background {#Sec1}
==========

Autism spectrum disorder (ASD) is a behaviorally defined developmental disorder with a strong genetic component \[[@CR1], [@CR2]\]. The identification of genetic risk factors such as common genetic variants, rare inherited and *de novo* mutations have lead to the implication of hundreds of different genes \[[@CR3], [@CR4]\]. These findings illustrate the complexity and heterogeneity of the genetic architecture of ASD.

Subsequently, mouse models are being used to unravel the functional impact of implicated genes on ASD phenotypes in a controlled genetic and environmental background. However, knowledge of the impact on cognitive and behavioral development of the majority of these genes is missing or incomplete \[[@CR5]\], and most behavioral characterizations of animal models are limited to adult phenotypes disregarding the developmental nature of ASD \[[@CR6]\].

Here, we characterize the impact of *contactin 4* (*Cntn4*) null mutation on behavioral development, using our recently developed longitudinal test battery for mice that tests a wide array of neurological, cognitive, and behavioral parameters across development starting from 3 weeks of age \[[@CR6]\].

CNTN4 is an axonal glycoprotein belonging to the contactin family, a six-member subgroup of the immunoglobulin superfamily of cell adhesion molecules \[[@CR7]\]. CNTN4 is known to act as an axon guidance molecule in the establishment of olfactory neural circuitry during neural development \[[@CR8]\] and promotes target-specific axon arborization of a subset of retinal ganglion cells onto the nucleus of the optic tract \[[@CR9]\]. Knowledge of the neurobiological functions of CNTN4 in normal and abnormal development of brain systems are far from complete.

The *CNTN4* gene has been implicated in ASD due to its presence in the genetic locus of the 3p-deletion syndrome, a mental retardation syndrome \[[@CR10]\]. Subsequently, evidence for a role of CNTN4 has been accumulated \[[@CR11]--[@CR14]\] but has also been questioned \[[@CR15], [@CR16]\]. Three cases carrying a copy number variant (CNV) in the *CNTN4* gene were reported by the Autism Genome Project Consortium (AGP) \[[@CR12]\]. Deletions and duplications in the *CNTN4* gene or its promoter region were found in 10 families of the Autism Genetic Resource Exchange (AGRE) collection \[[@CR13]\]. In the Autism Case-Control cohort (ACC), deletion in the promoter region of *CNTN4* was found in three cases but not in controls \[[@CR13]\]. Association of *CNTN4* with developmental disorders such as ASD further seems supported by the protein's neurobiological functions \[[@CR2], [@CR7]\].

Follwoing these observations, we performed a careful longitudinal functional characterization of homozygous and heterozygous disruptions of *Cntn4* to resolve the impact of this gene on behavioral and cognitive development.

Methods {#Sec2}
=======

Generation and breeding of *Cntn4* mice {#Sec3}
---------------------------------------

*Cntn4*-deficient mice were kindly provided by Dr. Yoshihiro Yoshihara (RIKEN, Japan) \[[@CR8]\]. These mice were generated using a standard gene-targeting method as previously described. A targeting vector was designated to mutate the translation start codon (ATG) in the exon 2 of the *Cntn4* gene into a stop codon (TAG) and introduce a pgk-neo selection marker. Consequently, these mice were backcrossed with C57BL/6 mice more than nine times. Upon arrival in the University Medical Center Utrecht, the mice were re-derived, followed by heterozygous breeding for the use in our experiments.

All animals were born and weaned at the University Medical Center Utrecht. Average nest size of Cntn4 litters was 7.2, and the litters larger than 10 animals per litter were culled back to average 7. The minimum litter size used for behavioral experiments was four animals per litter. Detailed information on the genotyping of *Cntn4* mice is provided in Additional file [1](#MOESM1){ref-type="media"}.

Given the extensive number of tests, the mice were spread over four different batches. Table [1](#Tab1){ref-type="table"} provides the order of behavioral testing and the number of animals per genotype per batch. Phenotypic assessments in batches 1, 2, and 3 were performed at the University Medical Center Utrecht. Batch 4 was transported and tested at Sylics (Synaptologics BV, Amsterdam, The Netherlands).Table 1Overview of the behavioral tests per batchAgeTaskBatchSubjects (*n*)3 weeksJuvenile social interactionBatch 1 + 26--7 genotype-matched pairs per genotype4 weeksExtended SHIRPA screenBatch 1 + 219--26 per genotype6 weeksExtended SHIRPA screenBatch 1 + 219--26 per genotype8 weeksExtended SHIRPA screenBatch 1 + 219--26 per genotypeAdultExtended SHIRPA screenBatch 110--15 per genotypeOpen fieldBatch 110--15 per genotypeElevated plus mazeBatch 110--15 per genotypeSocial discriminationBatch 110--15 per genotypeBuried food testBatch 29--11 per genotypeSet shifting-reversal taskBatch 29--11 per genotypeSocial approach in 3-chamberBatch 312 per genotypeNovel object exploration taskBatch 312 per genotypeBarnes maze-reversal taskBatch 416 per genotypePre-pulse inhibitionBatch 416 per genotypeAnimals in batch 1 + 2 were weaned at post-natal day 21. Batch 3 + 4 animals were weaned at post-natal day 28

All experiments were approved by the ethical committee for animal experimentation of the University Medical Center Utrecht and Free University Amsterdam and performed according to the institutional guidelines that are in full compliance with the European Council Directive (86/609/EEC).

Developmental neurological and behavioral screening {#Sec4}
---------------------------------------------------

*Cntn4*^*−/−*^, *Cntn4*^*+/−*^, and wild-type male littermates were subjected to our previously described longitudinal screening strategy (extended SHIRPA battery) testing an array of neurological, behavioral, and cognitive parameters at 4, 6, 8, and 11 weeks of age \[[@CR6], [@CR17]\]. The longitudinal test battery includes the assessment of autism-related traits such as motor stereotypies (e.g., self-grooming) and sensorimotor coordination (e.g., latency to fall from the rotarod). Detailed information on behavioral testing is provided in Additional file [1](#MOESM1){ref-type="media"}.

Screening of social behaviors and restricted repetitive behaviors {#Sec5}
-----------------------------------------------------------------

Abnormalities in social interaction behaviors were assessed in the juvenile social interaction test (3 weeks of age) \[[@CR18]\], followed by a three-chamber social approach \[[@CR18]\], and a 2-day social discrimination paradigm in adult age animals \[[@CR19]\]. Stereotypic movements, restricted interests, and repetitive patterns of behavior were analyzed in the novel object investigation task during exposure to four novel toys \[[@CR20]\]. Cognitive flexibility was assessed by multi-trial associative learning in an extensive set-shifting paradigm \[[@CR6]\], as well as a Barnes maze spatial learning task including reversal \[[@CR21]\]. Acoustic startle response and sensorimotor gating were assessed in the pre-pulse inhibition (PPI) test \[[@CR19]\]. Anxiety-related behaviors were tested in the elevated plus maze and open field \[[@CR6]\]. Statistical analyses are described in the Additional file [1](#MOESM1){ref-type="media"}.

Results {#Sec6}
=======

eSHIRPA assays {#Sec7}
--------------

The eSHIRPA (extended SmithKline Beecham, Harwell, Imperial College and Royal London Hospital phenotype assessment) screen did not show differences between the *Cntn4*^*+/−*^ mice, *Cntn4*^*−/−*^ mice, and wild-type controls at 4, 6, 8, or 10 weeks of age in general health, body weight, and neurological reflexes nor in the development of various locomotor parameters including total distance moved, movement velocity, and movement duration (Figs. [1a](#Fig1){ref-type="fig"}--[d](#Fig1){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}). Moreover, we found no developmental differences in the amount of self-grooming or sensorimotor coordination on the rotarod (Figs. [1e](#Fig1){ref-type="fig"}--[f](#Fig1){ref-type="fig"}).Fig. 1Developmental neurological and behavioral screen and analysis of social behaviors in *Cntn4-*deficient mice. **a** Distance moved (rmANOVA genotype, *F* ~(2,63)~ = 0.760, *p* = .472), **b** movement velocity (rmANOVA genotype, *F* ~(2,63)~ = 1.256, *p* = .292), **c** movement duration (rmANOVA genotype, *F* ~(2,63)~ = 0.342, *p* = .479), **d** body weight (rmANOVA genotype, *F* ~(2,63)~ = 0.588, *p* = .558), **e** latency to fall of the accelerating rotarod (rmANOVA genotype, *F* ~(2,64)~ = 0.110, *p* = .896), and **f** time spent self-grooming (rmANOVA genotype, *F* ~(2,64)~ = 1.038, *p* = .360) at pre-adolescence (4 weeks), adolescence (6 weeks), early adulthood (8 weeks), and adulthood (10 weeks) (*n* = 19--26 per genotype) during the eSHIRPA test. **g** Social sniffing (owANOVA, *F* ~(2,16)~ = 2.926, *p* = .083), anogenital sniffing (owANOVA, *F* ~(2,16)~ = 0.055, *p* = .946), and social grooming (owANOVA, *F* ~(2,16)~ = 0.334, *p* = .721) during the juvenile social interaction test in genotype-matched mice at post-natal day 21 (*n* = 6--7 pairs of genotype-matched interacting animals per genotype). **h** Social exploration (owANOVA between genotypes, *F* ~(2,32)~ = 0.599, *p* = .556) as a function of exploration of the cage with the novel mouse versus the empty cage during the three-chamber task (*n* = 12 per genotype). **i** Social exploration during the social discrimination test following a 5-min inter-trial interval (owANOVA between genotypes *F* ~(2,36)~ = 0.138, *p* = .872) and a 24-h inter-trial interval (owANOVA between genotypes *F* ~(2,36)~ = 0.096, *p* = .909), with exploration of the novel mouse as fraction of the total duration of social exploration (*n* = 10--15 per genotype). Data are presented as means ± SEM. \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001; \#*p* \< 0.05Table 2Physical and neurological features during the different phases of the extended SHIRPA primary screen.Age (weeks)468AdultTestWT+/−−/−Sig.WT+/−−/−Sig.WT+/−−/−Sig.WT+/−−/−Sig.Subjects (*n*)192622192622192622131510Body position (active)95961000.221001001001.00100961000.461001001001.00Body position (inactive)040000040000Body position (excessive activity)500000000000Tremor (absent)1001001001.001001001001.001001001001.001001001001.00Palpebral closure (eyes open)1001001001.001001001001.001001001001.001001001001.00Coat appearance tidy and groomed1001001001.001001001001.001001001001.001001001001.00Whiskers (present)1001001001.001001001001.001001001001.001001001001.00Lacrimation (absent)100961000.451001001001.001001001001.001001001001.00Defecation (quantity)1.91.62.00.473.12.51.90.062.82.32.40.613.83.73.20.70± SEM0.30.30.30.30.30.30.40.30.40.70.70.9Transfer arousal (brief freeze)1115140.70111990.7111800.1680100.50Transfer arousal (immediate movement)89858689819189921009210090Gait (fluid)1001001001.001001001001.001001001001.001001001001.00Tail elevation (horizontal extension)1001001001.00951001000.281001001001.001001001001.00Tail elevation (straub tail)000500000000Startle response (preyer reflex)1001001001.001001001001.001001001001.001001001001.00Touch escape (flight prior to touch)7973770.888985730.356388680.0585871000.45Touch escape (response to touch)21272311152737123215130Positional passivity (struggles)1001001001.001001001001.001001001001.001001001001.00Skin color (pink)951001000.281001001001.001001001001.001001001001.00Skin color (blanched)500000000000Trunk curl (absent)1001001001.001001001001.001001001001.001001001001.00Limb grasping (absent)100921000.201001001001.001001001001.001001001001.00Pinna reflex (present)1001001001.001001001001.001001001001.001001001001.00Corneal reflex (present)1001001001.001001001001.001001001001.001001001001.00Contact righting reflex (present)1001001001.001001001001.001001001001.001001001001.00Evidence of biting (none)7977770.9984881000.181001001001.001001001001.00Grip (OK)100961000.3695961000.591001001001.00100100900.24Full puberty89811000.301001001001.001001001001.001001001001.00*Cntn4* ^+/−^, *Cntn4* ^−/−^, and wild-type (WT) control mice were screened in the Perspex jar for body position (active, inactive, or excessively active), tremor (present or not), palpebral closure (eyes open or not), coat appearance (well groomed or irregularities like piloerection), whiskers (intact or trimmed), and lacrimation (present or not). In the arena, the mice were screened for transfer arousal (freezing or immediate movement), gait (fluid or not), tail elevation (dragging, horizontal, or straub tail), startle response (preyer reflex, no response, or additional response), and touch escape (response to touch or flight prior to touch while finger approaches). Mice were transferred out of the arena to observe positional passivity (struggling by different types of handling), skin color (color of plantar surface of forelimbs), trunk curl (forward curling with head to abdomen), limb grasping (clasping of rear limbs), pinna reflex (presence of ear retraction), corneal reflex (presence of eyeblink), contact righting reflex, evidence of biting, grip (grasping of grid), vocalization, and puberty (presence of sex organs). *Sig. *represents statistical significance of between-genotype differences. Data are presented as a percentage of the total number of animals per genotypes, except for defecation (count of the fecal boli)

Social interaction behavior {#Sec8}
---------------------------

The juvenile social interaction test revealed no differences in the amount of social sniffing, anogenital sniffing, or social grooming (Fig. [1g](#Fig1){ref-type="fig"}) between the *Cntn4*^*+/−*^, *Cntn4*^*−/−*^, and wild-type control mice. In the adult three-chamber test, all genotypes showed a clear preference for exploration of a mouse over an object, and no genotype differences in the amount of social exploration were observed (Fig. [1h](#Fig1){ref-type="fig"}). Furthermore, genotypes were equally capable to distinguish between a familiar mouse and a novel mouse in a social recognition paradigm, both at 5 min and 24 h after initial exposure (Fig. [1i](#Fig1){ref-type="fig"}).

Restricted and repetitive behaviors {#Sec9}
-----------------------------------

There were no differences in the grooming behavior between the *Cntn4*^*+/−*^, *Cntn4*^*−/−*^, and wild-type control mice at adult age, in line with the amount of grooming observed in the longitudinal eSHIRPA screening (Fig. [2a](#Fig2){ref-type="fig"}). We also found no genotype differences in restricted interest or in repetitive patterns of behavior in the novel object investigation task during the exploration of the four novel toys (Fig. [2b](#Fig2){ref-type="fig"}, [c](#Fig2){ref-type="fig"}).Fig. 2Restricted repetitive behaviors and sensory-sensitivity screening of adult *Cntn4* mice. Restricted and repetitive behavior in the novel object investigation task. **a** Stereotypic movements as total time spent grooming (owANOVA, *F* ~(2,33)~ = 0.431, *p* = .653). **b** Restricted interest as frequency-based percentage preference of exploration of each of the four novel toys (1st preference owANOVA, *F* ~(2,33)~ = 0.446, *p* = .644; 2nd preference owANOVA, *F* ~(2,33)~ = 1.569, *p* = .223; 3rd preference owANOVA, *F* ~(2,33)~ = 1.208, *p* = .312; 4th preference owANOVA, *F* ~(2,33)~ = 0.236, *p* = .791). **c** Repetitive toy exploration patterns based on repetitive sequences of three elements (owANOVA, *F* ~(2,33)~ = 0.760, *p* = .476) and four elements (owANOVA, *F* ~(2,33)~ = 0.227, *p* = .798) (*n* = 12 per genotype). **d** Reversal learning during the set-shifting reversal-learning task. *X*-axis represents the different sub-tasks. *Y*-axis represents the total number of trials that were needed to reach the criterion of 8 correct digs in 10 consecutive trials (*n* = 9--11 per genotype). **e--f** Spatial learning and reversal learning during the Barnes maze paradigm. *Y*-axis represents the daily mean of latency to find the escape hole during **e** the acquisition phase (rmANOVA genotype, *F* ~(2,44)~ = 4.151, *p* = .022) and **f** the reversal-learning phase (rmANOVA genotype, *F* ~(2,43)~ = 0.830, *p* = .830) after replacing the escape to the other side of the maze (*n* = 16 per genotype). Startle and PPI results in *Cntn4* mice, with **g** startle magnitude as function of startle stimulus in all genotypes (MANOVA, *F* ~(24,70)~ = 1.984, *p* = 0.014), **h** startle threshold (owANOVA, *F* ~(2,45)~ = 1.542, *p* = 0.225), **i--j** pre-pulse inhibition tested with different pre-pulse intensities with inter-stimulus interval (ISI) at 30 ms (two-way ANOVA, *F* ~(2,135)~ = 2.376, *p* = 0.096) and at 100 ms (two-way ANOVA, *F* ~(2,135)~ = 1.1927, *p* = 0.306; *n* = 16 per genotype). Anxiety behavior during the elevated plus maze test and open-field test measured as **k** elevated plus maze anxiety and as total time spent on the open arms (owANOVA, *F* ~(2,36)~ = 1.450, *p* = 0.248), **l** total time spent in the center (owANOVA, *F* ~(2,36)~ = 0.165, *p* = 0.848), middle (owANOVA, *F* ~(2,36)~ = 0.413, *p* = 0.665), and outer zones (owANOVA, *F* ~(2,36)~ = 0.125, *p* = 0.883) of the open field (*n* = 10--15 per genotype). Data are presented as means ± SEM; \**p* \< 0.05. *SD* simple discrimination, *CD* compound discrimination, *IDS I--IV* intra-dimensional shift I--IV, *IDS-reversal* reversal of intra-dimensional shift IV (owANOVA, *F* ~(2,27)~ = 3.487, *p* = .045; Dunnett's *t*, WT vs HET *p* = 0.037, WT vs KO *p* = 0.092), *EDS* extra-dimensional shift (owANOVA, *F* ~(2,27)~ = 1.416, *p* = .260)

We additionally analyzed cognitive flexibility through the assessment of reversal learning in a set-shifting task. Prior to this task, we ascertained intact olfactory capacities, as we found no genotype differences in the latency to find a buried piece of food. In the set-shifting task, all genotypes were equally able to associate a food reward with a specific digging material or odor, as was evident through the performance of simple, compound discrimination and intra- and extra-dimensional shifts (Fig. [2d](#Fig2){ref-type="fig"}).

The reversal-learning phase of this test yielded an inconclusive result, as the genotype effect that we observed on reversal learning was only significant (ANOVA *p* = 0.04) in one of the two outcome measures (i.e., the number of trials to reach the criterion but not in errors to reach criterion). Moreover, a shift cost in wild-type mice was observed in errors to reach criterion, although not in the number of trials to reach criterion. Given this inconclusive result, we tested reversal-learning performance in a different paradigm. In this Barnes maze reversal-learning paradigm, we confirmed that *Cntn4*does not affect reversal learning, as all genotypes needed equal amount of time as well as distance before reaching the re-located escape hole (Fig. [2f](#Fig2){ref-type="fig"}). In contrast to the set-shifting test, we observed a shift cost that was observed in all genotypes in the reversal phase of the Barnes maze test (Fig. [2e](#Fig2){ref-type="fig"}, [f](#Fig2){ref-type="fig"}).

Responses to sensory stimuli and anxiety-related behaviors {#Sec10}
----------------------------------------------------------

The startle response was consistently increased in the *Cntn4*^*+/−*^ and *Cntn4*^*−/−*^ mice at different high amplitudes, although the startle threshold was not significantly different between genotypes (Figs. [2g](#Fig2){ref-type="fig"}, [h](#Fig2){ref-type="fig"}). No significant effects were found on pre-pulse inhibition at both inter-stimulus intervals of 30 and 100 ms (Figs. [2i](#Fig2){ref-type="fig"}, [j](#Fig2){ref-type="fig"}).

The increased startle response to auditory stimuli of the different high amplitudes seemed not to result from increased anxiety levels, as *Cntn4*^*+/−*^, *Cntn4*^*−/−*^ mice and wild-type controls did not differ in their elevated plus maze (Fig. [2k](#Fig2){ref-type="fig"}) and open-field exploratory behaviors (Figs. [2l](#Fig2){ref-type="fig"}).

Discussion {#Sec11}
==========

We present a comprehensive assessment of the impact of the ASD candidate gene *CNTN4* on a variety of neurological, behavioral, and cognitive aspects of development. We found no effect of *Cntn4* deficiency on ASD-related behavioral mouse paradigms such as the juvenile social interaction test, the three-chamber test, grooming behavior, and sensorimotor coordination. We also did not observe developmental neurological, behavioral, or cognitive abnormalities in the extended SHIRPA screen.

The reversal-learning phase of the set-shifting task yielded an inconclusive result, as no shift cost was observed in wild-type animals for the number of trials to reach criterion. Indeed, the genotype difference that was observed in the number of trials to reach the criterion in the reversal-learning phase was rather caused by lack of shift cost in wild-type animals than a reversal-learning deficit in the *Cntn4*^−/−^ mice. In line with this reasoning, when we compared the outcome of *Cntn4*^−/−^ mice in the reversal-learning phase with the results obtained for C57BL/6J mice obtained in a previous study, we find no genotype difference in this phase of the set-shifting task \[[@CR6]\]. In the Barnes maze reversal-learning paradigm, we also did not find a reversal-learning deficit. Based on the summary of these data, we conclude that *Cntn4* disruption has no effect on cognitive flexibility.

Non-ASD-specific effects at adult ages were indicated by increased startle response to auditory stimuli of different high amplitudes and by faster escape hole finding during subsequent days of acquisition in the Barnes maze.

Hyperresponsivity to acoustic stimuli is related to many neurodevelopmental disorders and has also been reported in ASD \[[@CR22]\]. In addition, acoustic hyperresponsivity in patients with fragile X syndrome is known to be consistent with animal model data \[[@CR23]\]. Similar to our findings, an increased startle response to acoustic stimuli was recently described in children with ASD \[[@CR24]\], although these were in response to weak stimuli in contrast to the high amplitudes we found. The observed hyperresponsivity in *Cntn4*-deficient mice was unrelated to anxiety levels, as mice showed similar exploratory behaviors in classical anxiety behavioral tests, such as the elevated plus maze and open field. Although speculative, the increased startle response together with the enhanced acquisition in the Barnes maze could indicate that *Cntn4* deficiency in the C57BL/6J background leads to a state of increased behavioral responsiveness without overt anxiety or avoidance behavior in mice \[[@CR25]\].

Together, the findings show that in the C57BL/6J background, disruption of *Cntn4* does not lead to substantial behavioral defects related to autistic development. A limited behavioral penetrance of *CNTN4* mutations on autistic development may be consistent with a recent study that revisited the association of contactins, including *CNTN4*, with ASD \[[@CR16]\]. The behavioral phenotype of *Cntn4* mice contrasts other previously studied genetic ASD models \[[@CR18]\]. For instance, *Shank3* or *Pten* mice show extensive impairments in social interaction and sensorimotor phenotypes and are therefore regarded as translational models for ASD \[[@CR26]--[@CR28]\].

Although ASD-related phenotypes in *Cntn4*-deficient mice were observed, our findings do have relevance for neurodevelopmental disorder research. The specific phenotypes observed in *Cntn4*-deficient mice may be used to study the mechanisms underlying increased responsiveness or vigilance, a trait observed across many different human disorders such as attention-deficit hyperactivity disorder, post-traumatic stress disorder, and schizophrenia \[[@CR29]--[@CR31]\]. *Cntn4*-deficient mice may serve as a model to study the mechanistic underpinnings of behavioral states in which vigilance is altered. Indeed, common single-nucleotide variants in the *CNTN4* locus have recently been associated with other neuropsychiatric disorders, such as schizophrenia \[[@CR32]\], perhaps pointing to a non-disorder specific contribution of this cell adhesion gene in neuropsychiatric pathogenesis. In addition, a role for *Cntn4*, was recently shown in target-specific arborization during development of the accessory optic system \[[@CR9]\]. Our study shows the importance of detailed developmental neurological, behavioral, and cognitive characterization of genetic animal models to complement human genetic studies in ASD and related disorders.

Conclusions {#Sec12}
===========

In our test battery, disruption of *Cntn4*, a prominent ASD candidate gene*,* had no effect on cognitive and behavioral development or ASD-specific phenotypes. At adult age, we could detect an effect of *Cntn4* disruption on an adult sensory behavioral and a spatial cognitive feature.

Additional file {#Sec13}
===============

Additional file 1:Detailed information on genotyping, behavioral testing and statistical analyses.
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:   autism spectrum disorder

eSHIRPA

:   extended SmithKline Beecham, Harwell, Imperial College and Royal London Hospital phenotype assessment
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